News - Respiratory and Pulmonary

Filter

Current filters:

Respiratory and Pulmonary

Popular Filters

101 to 125 of 360 results

AstraZeneca advances Medimmune’s benralizumab to Phase III in severe asthma

AstraZeneca advances Medimmune’s benralizumab to Phase III in severe asthma

30-10-2013

AstraZeneca has started the Phase III Windward program for benralizumab, a potential treatment for severe…

AstraZenecaEuropeKyowa Hakko KirinMedImmunePharmaceuticalResearchRespiratory and Pulmonary

Positive EMA/CHMP opinions for Actelion and Lundbeck

Positive EMA/CHMP opinions for Actelion and Lundbeck

27-10-2013

At its October month-end meeting, the European Medicines Agency’s Committee for Medicinal Products…

ActelionBiotechnologyBrintellixEuropeLundbeckNeurologicalOpsumitPharmaceuticalRegulationRespiratory and Pulmonary

Forest Labs reports rise in sales and EPS doubles in second quarter results

23-10-2013

Forest Laboratories has released its second quarter results which showed that net sales for the quarter…

BystolicCNS DiseasesDalirespFinancialForest LaboratoriesLinzessNamendaNorth AmericaPharmaceuticalRespiratory and PulmonarySavellaTeflaroTudorza PressairViibryd

Stallergenes and DBV Technologies collaborate in birch pollen allergy research

18-10-2013

French allergy specialists Stallergenes and DBV Technologies, creator of Viaskin for the treatment of…

DBV TechnologiesImmunologicalsPharmaceuticalResearchRespiratory and PulmonaryStallergenes

FDA allows OTC of Sanofi’s Nasacort

FDA allows OTC of Sanofi’s Nasacort

13-10-2013

The US Food and Drug Administration has approved Sanofi’s Nasacort Allergy 24HR nasal spray as an over-the-counter…

ChattemNasacort AQNorth AmericaPharmaceuticalRegulationRespiratory and PulmonarySanofi

Analysts recommend GSK after Teva announces Advair generic delay

Analysts recommend GSK after Teva announces Advair generic delay

11-10-2013

The delay for the generic version of GlaxoSmithKline’s Advair coupled with the advances in the company’s…

AdvairdarapladibEuropeFinancialGlaxoSmithKlineNeurologicalPharmaceuticalRespiratory and PulmonaryTeva Pharmaceutical Industries

Global asthma treatment market to reach $21.6 billion by 2019

09-10-2013

The global asthma treatment market is estimated to reach a value of $21.6 billion by 2019, due not only…

GlaxoSmithKlineGlobalMarkets & MarketingPharmaceuticalRelvarRespiratory and Pulmonary

FDA approves Bayer’s Adempas; firm accelerates drug candidates

FDA approves Bayer’s Adempas; firm accelerates drug candidates

09-10-2013

The US Food and Drug Administration late yesterday approved Adempas (riociguat), developed by German…

AdempasBayerCardio-vascularcopanlisibfinerenoneNorth AmericaOncologyPharmaceuticalRegulationResearchRespiratory and PulmonaryWomen's Health

US FDA backs updated product specifications for Surfaxin

04-10-2013

Discovery Laboratories says that the US Food and Drug Administration has agreed to the company's updated…

Discovery LaboratoriesNorth AmericaPharmaceuticalRegulationRespiratory and PulmonarySurfaxin

Vectura and UCB to collaborate on severe inflammatory disease

Vectura and UCB to collaborate on severe inflammatory disease

30-09-2013

Vectura and UCB have entered into a collaboration for the development of an innovative biologic immuno-modulatory…

BiotechnologyEuropeInflammatory diseasesPharmaceuticalResearchRespiratory and PulmonaryUCBVectura

Bayer gains two orphan drug designations for riociguat

Bayer gains two orphan drug designations for riociguat

26-09-2013

Bayer’s investigational drug riociguat has been granted two orphan drug designations by the US Food…

BayerNorth AmericaPharmaceuticalRegulationRespiratory and Pulmonaryriociguat

Galapagos and AbbVie enter into cystic fibrosis alliance

Galapagos and AbbVie enter into cystic fibrosis alliance

24-09-2013

Belgium-based Galapagos and US drugmaker AbbVie have entered into a global alliance to discover novel…

GlobalPharmaceuticalResearchRespiratory and Pulmonary

Novartis gains EU and Japan approval for COPD treatments

Novartis gains EU and Japan approval for COPD treatments

24-09-2013

Swiss drug major Novartis has received approval from the European Commission for once-daily Ultibro Breezhaler…

EuropeNovartisPharmaceuticalRegulationRespiratory and PulmonaryUltibro Breezhaler

IN FOCUS: A post-ERS look at Verona Pharma’s respiratory pipeline

IN FOCUS: A post-ERS look at Verona Pharma’s respiratory pipeline

20-09-2013

Fresh from their trip to the European Respiratory Society annual congress in Barcelona, Verona Pharma’s…

EuropeInterviewsPharmaceuticalResearchRespiratory and Pulmonary

Positive CHMP recommendation for Relvar Ellipta

20-09-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) announced that the…

EuropeGlaxoSmithKlinePharmaceuticalRegulationRespiratory and PulmonaryTheravance

Flutiform trial for COPD initiated in Europe

Flutiform trial for COPD initiated in Europe

19-09-2013

UK drug delivery specialist Skyepharma (LSE: SKP) and privately-held Swiss drugmaker Mundipharma, which…

FlutiformMundipharmaPharmaceuticalResearchRespiratory and PulmonarySkyepharma

FDA advisory panel gives thumbs up for Anoro Ellipta approval

11-09-2013

There was a bit of good news for UK pharma giant GlaxoSmithKline yesterday (LSE: GSK) and partner USA-based…

Anoro ElliptaGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryTheravance

Generic risk to GSK's Advair prompts buy recommendation from analysts

10-09-2013

Pharmaceutical analysts are urging investors to buy shares of UK pharma major GlaxoSmithKline (LSE: GSK)…

AdvairAstraZenecaBoehringer IngelheimEuropeFinancialGlaxoSmithKlinePharmaceuticalRespiratory and PulmonarySandozSpirivaSymbicort

COPD trial shows comparable efficacy in Boehringer's Spiriva Respimat and HandiHaler

09-09-2013

One of largest chronic obstructive pulmonary disease (COPD) trials conducted to date confirms comparable…

Boehringer IngelheimEuropePharmaceuticalResearchRespiratory and PulmonarySpiriva

GSK's Anoro Ellipta shows efficacy in COPD, say FDA briefing papers

09-09-2013

UK drug major GlaxoSmithKline's (LSE: GSK) Anoro Ellipta (vilanterol/umeclidinium) to treat chronic obstructive…

Anoro ElliptaBreo ElliptaGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryTheravance

Further evidence of Ultibro Breezhaler efficacy showcased at ERS meeting

09-09-2013

Swiss drug major Novartis (NOVN: VX) released date data from new analyses for once-daily Ultibro Breezhaler…

NovartisPharmaceuticalResearchRespiratory and PulmonarySeebri BreezhalerUltibro BreezhalerVectura

Tris Pharma and FSC Labs enter Karbinal accord

04-09-2013

Drug delivery specialist Tris Pharma and fellow USA-based privately-held company FSC Laboratories have…

FSC LaboratoriesKarbinalLicensingNorth AmericaPharmaceuticalRespiratory and PulmonaryTris Pharma

Further highlights from European Society of Cardiology meeting

03-09-2013

The ongoing European Society of Cardiology meeting in Amsterdam, Netherlands, continues to produce both…

ActelionalogliptinAmgenBiotechnologyCardio-vascularCytokineticsDiabetesomecamtiv mecarbilOpsumitPharmaceuticalResearchRespiratory and PulmonaryTakeda Pharmaceuticals

101 to 125 of 360 results

Back to top